Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Lyglim-VM 2mg/500mg/0.2mg Tablet

Prescription Icon
Prescription Required

Marketer

Lyrid Healthcare Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Lyglim-VM 2mg/500mg/0.2mg Tablet

Diabetace-Trio 2mg/500mg/0.2mg tablets are classified as antidiabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose levels. Administer Diabetace-Trio with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your glycemic control. Continued use is crucial, even with well-managed blood sugar, as discontinuation without medical supervision can elevate blood glucose, increasing the risk of nephropathy, retinopathy, neuropathy, and limb loss. Remember, this medication is part of a comprehensive diabetes management plan that includes diet, exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a frequent adverse effect. Learn to identify symptoms such as sweating, lightheadedness, headache, and tremors, and know how to treat it. Regular meals and readily available glucose sources (e.g., sugary snacks or juice) are essential for prevention. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, visual disturbances, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your doctor before initiating treatment. Pregnant or lactating women should consult their physician. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to monitor blood cell counts and liver function.

Uses of Lyglim-VM 2mg/500mg/0.2mg Tablet

Managing type 2 diabetes

Major Benefits of Lyglim-VM 2mg/500mg/0.2mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. Administer Lyglim-VM 2mg/500mg/0.2mg tablets on an empty stomach.

Common Side effects of Lyglim-VM 2mg/500mg/0.2mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Lyglim-VM 2mg/500mg/0.2mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Lyglim-VM 2mg/500mg/0.2mg Tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.

How Lyglim-VM 2mg/500mg/0.2mg Tablet works:

Each Lyglim-VM tablet (2mg/500mg/0.2mg) contains a triple-action antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Lyglim-VM 2mg/500mg/0.2mg tablets is dangerous.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Lyglim-VM 2mg/500mg/0.2mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against possible risks prior to prescribing this medication. Patient consultation with their doctor is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Lyglim-VM 2mg/500mg/0.2mg tablets while breastfeeding is likely inadvisable. Available evidence in humans indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyUNSAFE

Employing Lyglim-VM 2mg/500mg/0.2mg tablets in individuals with kidney impairment poses a likely risk and is best avoided. A physician's consultation is advised. Furthermore, this medication is unsuitable for patients exhibiting severe kidney dysfunction.

LiverLiverCAUTION

Patients with liver impairment should use Lyglim-VM 2mg/500mg/0.2mg tablets cautiously. Dosage modification may be necessary. Consult a physician. For those with mild to moderate liver disease, initiation should be at a low dose; the tablet is contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Lyglim-VM 2mg/500mg/0.2mg Tablet :

Should you forget to take your Lyglim-VM 2mg/500mg/0.2mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Lyglim-VM 2mg/500mg/0.2mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Lyglim-VM 2mg/500mg/0.2mg Tablet

Lyglim-VM 2mg/500mg/0.2mg tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas; metformin reduces liver glucose production and enhances insulin sensitivity; and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose levels. This medication is not suitable for type 1 DM.
Lyglim-VM 2mg/500mg/0.2mg Tablets may cause common side effects including low blood sugar (hypoglycemia), nausea, diarrhea, altered taste, gas, stomach pain, headache, skin rash, and respiratory infections.
Lyglim-VM 2mg/500mg/0.2mg Tablets are contraindicated in patients with allergies to any ingredient or excipient. This medication should also be avoided in patients with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcers, or underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Lyglim-VM 2mg/500mg/0.2mg tablets with alcohol is unsafe. This combination may worsen low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Lyglim-VM 2mg/500mg/0.2mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Lyglim-VM 2mg/500mg/0.2mg...
103
MRP 119
13% off